Advertisement
Canada markets closed

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7322
    -0.0001 (-0.02%)
     

  • CRUDE OIL

    83.86
    +0.29 (+0.35%)
     

  • Bitcoin CAD

    87,480.80
    -645.42 (-0.73%)
     

  • CMC Crypto 200

    1,388.18
    +5.60 (+0.41%)
     

  • GOLD FUTURES

    2,340.80
    -1.70 (-0.07%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,755.25
    +187.75 (+1.07%)
     

  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,617.98
    -10.50 (-0.03%)
     

  • CAD/EUR

    0.6823
    +0.0002 (+0.03%)
     

Here’s What Eli Lilly’s Latest Clinical Win Means For Investors

Prosper Junior Bakiny, The Motley Fool
·4 min read
Here’s What Eli Lilly’s Latest Clinical Win Means For Investors

Few pharmaceutical giants have performed as well or better than Eli Lilly (NYSE: LLY) in the stock market over the past year. The Indianapolis-based company's secret wasn't its financial results, as they were relatively mild, or even downright disappointing, for much of this period. The market is forward-looking, and with the drugmaker producing several highly promising programs, investors are increasingly excited regarding Eli Lilly's future.

Continue reading